Gland Pharma receives approval for cetrorelix acetate for injection
Gland Pharma Ltd. has received approval from the United States Food and Drug Administration (USFDA) for cetrorelix acetate for injection, 0.25 mg/vial, a single-dose vial. As per the stock exchange filing, the product is bioequivalent to the reference listed drug (RLD), cetrotide for injection, 0.25 mg/vial, of EMD Serono, Inc. According to IQVIA, the product […]